Kinshasa, DR Congo / RankWire.AI / – In the Democratic Republic of the Congo, health authorities have confirmed that the total number of infections in the latest epidemic has reached 3,075. This marks the moment when Congo Ebola cases cross 3,000, following an unprecedented surge in transmission. Official data from the health ministry reports 1,354 deaths and 556 full recoveries. Currently, 755 individuals are receiving care in hospitals or specialized isolation units. Declared on May 15, the outbreak is the fastest-growing on record. The number of cases surpassed 2,000 on July 15 and increased by another thousand in less than two weeks.

The outbreak is driven by the Bundibugyo strain of the Ebola virus, a rare variant for which there are no approved vaccines or targeted antiviral therapies at present. On May 17, the World Health Organization declared the outbreak in the Democratic Republic of the Congo and neighboring Uganda a public health emergency of international concern. International health officials considered the risk of regional spread to be high, largely due to cross-border population movements and ongoing conflict in affected provinces. Epidemiological data indicates that nearly 90 percent of confirmed infections are concentrated within Ituri, a northeastern province bordering South Sudan and Uganda.
During a briefing on the emergency response, Africa Centres for Disease Control and Prevention Director General Dr. Jean Kaseya highlighted the severe limitations faced by frontline health workers. Kaseya explained that many patients are dying because of critical shortages of medical therapeutics, protective gear, and international financial aid. The current outbreak has claimed lives more rapidly than the West Africa epidemic from 2013 to 2016, which resulted in over 11,000 deaths over two years. While previous outbreaks took about eight months to reach 1,000 fatalities, the Bundibugyo strain outbreak achieved this in just ten weeks.
Rising Case Numbers and Emergency Actions in the Region
Regional treatment centers are experiencing severe disruptions due to ongoing strikes by local healthcare workers demanding unpaid wages. DRC health officials clarified that although increased diagnostic capacity and expanded field testing have led to higher case detection, administrative delays and logistical issues hinder containment efforts. Hospital staff in eastern provinces continue to demand immediate government disbursements for risk allowances and operational funding. Public health officials warn that ongoing labor strikes inside isolation facilities could lead to faster community transmission, especially in nearby rural areas.
In the absence of specific medical countermeasures, international scientists are speeding up vaccine trials. Researchers at Oxford University announced that a first group of human volunteers has received an experimental vaccine candidate aimed at neutralizing the Bundibugyo strain. Meanwhile, neighboring East African countries have intensified border screening protocols and distributed protective equipment at transit points. Governments in the region are collaborating with international health partners to prevent secondary chains of transmission from establishing within major urban transit hubs.
Epidemic Passes 3,000 Confirmed Cases
Epidemiological models reviewed by international health agencies suggest that the epidemic could last several more months before reaching its peak. Specialized medical airlifts organized by humanitarian organizations are delivering diagnostic reagents, protective gear, and hydration fluids to regional hospitals. Experts stress that maintaining stable supply lines to remote treatment centers is vital to reducing patient mortality. Community outreach programs are expanding to improve contact tracing and address public skepticism about medical isolation measures.
Global health organizations emphasize that ending the epidemic requires sustained international funding and immediate medical supplies. The response plan centers on strengthening local clinical capacity, ensuring health worker compensation, and deploying candidate vaccines under emergency protocols. Authorities believe that rapid deployment of experimental therapeutics combined with rigorous contact tracing offers the best strategy for reducing regional virus transmission and protecting vulnerable populations across Central Africa.